Inventor
COST GREGORY J
US25 patents
⚠️ This page may combine multiple inventors who share the name “COST GREGORY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANGAMO BIOSCIENCES INC
17 patentsUS7914796B2Mar 29, 2011
Engineered cleavage half-domains
SANGAMO BIOSCIENCES INC221 citations99
US9616090B2Apr 11, 2017
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
SANGAMO BIOSCIENCES INC51 citations98
US9873894B2Jan 23, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC86 citations97
US9902974B2Feb 27, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC29 citations94
US9222105B2Dec 29, 2015
Methods and compositions for modification of the HPRT locus
SANGAMO BIOSCIENCES INC16 citations92
US7919313B2Apr 5, 2011
Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression
SANGAMO BIOSCIENCES INC13 citations92
US10179918B2Jan 15, 2019
Methods and compositions for increasing transgene activity
SANGAMO BIOSCIENCES INC8 citations84
US9816074B2Nov 14, 2017
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
SANGAMO BIOSCIENCES INC7 citations84
US8895264B2Nov 25, 2014
Methods and compositions for modification of the HPRT locus
SANGAMO BIOSCIENCES INC10 citations84
US9970028B2May 15, 2018
Targeted genomic modification with partially single-stranded donor molecules
SANGAMO BIOSCIENCES INC8 citations83
US9963715B2May 8, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC3 citations73
US9650648B2May 16, 2017
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC4 citations73
US9322036B2Apr 26, 2016
Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression
SANGAMO BIOSCIENCES INC4 citations73
US10883119B2Jan 5, 2021
Methods and compositions for delivery of biologics
SANGAMO BIOSCIENCES INC0 citations62
US9890395B2Feb 13, 2018
Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression
SANGAMO BIOSCIENCES INC0 citations52
US10889834B2Jan 12, 2021
Methods and compositions for enhancing targeted transgene integration
SANGAMO BIOSCIENCES INC0 citations51
US10174331B2Jan 8, 2019
Methods and compositions for nuclease-mediated targeted integration of transgenes
SANGAMO BIOSCIENCES INC0 citations51
SANGAMO THERAPEUTICS INC
5 patentsUS10196651B2Feb 5, 2019
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC16 citations94
US10196652B2Feb 5, 2019
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC11 citations92
US10435677B2Oct 8, 2019
Genetically modified human cell with a corrected mutant sickle cell mutation
SANGAMO THERAPEUTICS INC8 citations84
US9833479B2Dec 5, 2017
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
SANGAMO THERAPEUTICS INC5 citations84
US11492643B2Nov 8, 2022
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC0 citations62